Journal
JOURNAL OF APPLIED PHYSIOLOGY
Volume 98, Issue 4, Pages 1503-1510Publisher
AMER PHYSIOLOGICAL SOC
DOI: 10.1152/japplphysiol.01140.2004
Keywords
oxygen measurement; Oxyphor G2; nitroimidazole; tissue oxygenation; hypoxia
Categories
Funding
- NCI NIH HHS [U54 CA-105008-01] Funding Source: Medline
- NIBIB NIH HHS [EB-001713-01] Funding Source: Medline
- NIDDK NIH HHS [P30-DK-50306] Funding Source: Medline
Ask authors/readers for more resources
In the present work, a novel method for detecting hypoxia in tumors, phosphorescence quenching, was used to evaluate tissue and tumor oxygenation. This technique is based on the concept that phosphorescence lifetime and intensity are inversely proportional to the oxygen concentration in the tissue sample. We used the phosphor Oxyphor G2 to evaluate the oxygen profiles in three murine tumor models: K1735 malignant melanoma, RENCA renal cell carcinoma, and Lewis lung carcinoma. Oxygen measurements were obtained both as histograms of oxygen distribution within the sample and as an average oxygen pressure within the tissue sampled; the latter allowing real-time oxygen monitoring. Each of the tumor types examined had a characteristic and consistent oxygen profile. K1735 tumors were all well oxygenated, with a peak oxygen pressure of 37.8 +/- 5.1 Torr; RENCA tumors had intermediate oxygen pressures, with a peak oxygen pressure of 24.8 +/- 17.9 Torr; and LLC tumors were all severely hypoxic, with a peak oxygen pressure of 1.8 +/- 1.1 Torr. These results correlated well with measurements of tumor cell oxygenation measured by nitroimidazole (EF5) binding and were consistent with assessments of tumor blood flow by contrast enhanced ultrasound and tumor histology. The results show that phosphorescence quenching is a reliable, reproducible, and noninvasive method capable of providing real-time determination of oxygen concentrations within tumors.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available